1. Abstract 1.1. Background: We evaluated the changes of biomarkers and their significance in patients with nonalcoholic fatty liver disease. 1.2. Methods: One hundred and ten nonalcoholic fatty liver disease patients were enrolled into experimental group and one hundred and ten healthy people into control group. The plasma levels of biomarkers were detected. 1.3. Results: …
1. Abstract Hepatocyte transplantation for acute liver failure and metabolic liver disorders represent a potential alternative to traditional orthotopic liver transplantation (OLT). Additionally, cultured primary hepatocytes are an important tool for in vitro pharmacological studies. Advances in clinical hepatocyte transplantation and drug studies depend on the development of standardized isolation and culturing protocols as well …
1. Abstract 1.1. Aim: The objective of study reported here was to evaluate the clinical efficacy, side effects and long survival time in the advanced stages of all solid tumors after the treatment of UMIPIC. 1.2. Methods: 581 patients with solid tumors in late stages were collected for retrospect analysis of their clinical efficacy, adverse …
1. Abstract 1.1. Aims: The purpose of this study was to describe Portosystemic Cannulation (PSC) Under Ultrasound (US) guidance to perform a Transjugular Intrahepatic Portosystemic Shunt (TIPS) placement. 1.2. Methods: Medical records of 23 patients who underwent TIPS procedure with US-guided PSC at our institute between October 2018 to December 2021 were reviewed, including for …
1. Abstract 1.1. Background Endoscopic ultrasonography (EUS) has become a reliable method for predicting the invasion depth of early gastric cancer (EGC). However, diagnostic accuracy of EUS is affected by several factors. In particular, it is difficult to differentiate between T1a and T1b EGC through EUS. The aim of this study was to confirm whether …
1. Abstract 1.1. Background Oncological survival after operation of resectable pancreatic ductal adenocarcinoma (R-PDAC) is variable depending on various factors. Preoperative risk stratification could guide decision-making in multidisciplinary treatment concepts. We develop and validate a prognostic score for disease-free survival (DFS) in R-PDAC to solve this issue.
1. Abstract 1.1. Background and Objetive: Irritable bowel syndrome (IBS) is presented as a biopsychosocial model according to Rome criteria. In Chile there are not studies on psychosocial risk factors (PRF) in IBS. The aim was to evaluate PRF in patients with IBS and their relationship with clinical severity, phenotypes and associated pathologies. 1.2. Methods …
Psychosocial Risk Factors in Chilean Patients with Irritable Bowel Syndrome Read More »
1. Abstract 1.1. Purpose To study the survival time of mice with tumor by intratumoral injection with chemotherapy drug Adr plus hapten of DNP or Hydra and find a combination of drugs of Adr with DNP or Hydra can prolong their life, and which one of DNP or Hydra can provide a long life extension …
1. Abstract 1. Aims: This study aims to compare the HR-QoL among rural Chinese patients with upper GI diseases at different pathological stages and to determine the factors influencing HR-QoL in this population. 1.2. Methods: A cross-sectional survey was conducted in two counties in Shandong province in China from July to September 2018. Demographic and …
1. Abstract 1.1. Background: Hepatitis C (HCV) is a serious public health problem with approximately 3% of the world’s population infected. Patients on chronic hemodialysis are known to be a population at risk of HCV infection worldwide. 1.2. Aims: This study aimed to estimate the serological prevalence of HCV and characterize the HCV viral load …
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.